Author:
Catlin Natasha R.,Stethem Christine,Bowman Christopher J.,Campion Sarah N.,Nowland William S.,Cappon Gregg D.
Reference27 articles.
1. Guideline on Reproductive Toxicology: Detection of Toxicity to Reproductive for Human Pharmaceuticals;ICH S5 (R3) Step 5,2020
2. The novel use of a heterozygous knockout mouse for embryofetal development assessment of a glucokinase activator;Mitchard;Birth Defects Res. B Dev. Reprod. Toxicol.,2014
3. Nonclinical Evaluation for Anticancer Pharmaceuticals;ICH S9 Step 4,2009
4. Severely Debilitating of Life-threatening Hematologic Disorders: Nonclinical Development of Pharmaceuticals. Guidance for Industry;Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER),2019
5. Goldilocks’ determination of what new in vivo data are “Just right” for different common drug development scenarios, part 1;Bowman;Birth Defects Res. B Dev. Reprod. Toxicol.,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献